Literature DB >> 31793158

Imidazotetrazines as Weighable Diazomethane Surrogates for Esterifications and Cyclopropanations.

Riley L Svec1, Paul J Hergenrother1.   

Abstract

Diazomethane is one of the most versatile reagents in organic synthesis, but its utility is limited by its hazardous nature. Although alternative methods exist to perform the unique chemistry of diazomethane, these suffer from diminished reactivity and/or correspondingly harsher conditions. Herein, we describe the repurposing of imidazotetrazines (such as temozolomide, TMZ, the standard of care for glioblastoma) for use as synthetic precursors of alkyl diazonium reagents. TMZ was employed to conduct esterifications and metal-catalyzed cyclopropanations, and results show that methyl ester formation from a wide variety of substrates is especially efficient and operationally simple. TMZ is a commercially available solid that is non-explosive and non-toxic, and should find broad utility as a replacement for diazomethane.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  alkylation; cyclopropanation; diazo compounds; diazomethane; imidazotetrazines

Mesh:

Substances:

Year:  2019        PMID: 31793158      PMCID: PMC6982548          DOI: 10.1002/anie.201911896

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  22 in total

1.  Carcinogenic action of diazomethane and of nitroso-n-methyl urethane.

Authors:  R SCHOENTAL
Journal:  Nature       Date:  1960-10-29       Impact factor: 49.962

2.  Continuous flow generation and reactions of anhydrous diazomethane using a Teflon AF-2400 tube-in-tube reactor.

Authors:  Federica Mastronardi; Bernhard Gutmann; C Oliver Kappe
Journal:  Org Lett       Date:  2013-10-15       Impact factor: 6.005

3.  Synthesis and biological characterisation of ester and amide derivatives of fusidic acid as antiplasmodial agents.

Authors:  Marlene Espinoza-Moraga; Kawaljit Singh; Mathew Njoroge; Gurminder Kaur; John Okombo; Carmen De Kock; Peter J Smith; Sergio Wittlin; Kelly Chibale
Journal:  Bioorg Med Chem Lett       Date:  2016-11-25       Impact factor: 2.823

Review 4.  Advances in the molecular genetics of gliomas - implications for classification and therapy.

Authors:  Guido Reifenberger; Hans-Georg Wirsching; Christiane B Knobbe-Thomsen; Michael Weller
Journal:  Nat Rev Clin Oncol       Date:  2016-12-29       Impact factor: 66.675

5.  Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent.

Authors:  M F Stevens; J A Hickman; R Stone; N W Gibson; G U Baig; E Lunt; C G Newton
Journal:  J Med Chem       Date:  1984-02       Impact factor: 7.446

6.  N,N'-ditosylhydrazine: a convenient reagent for facile synthesis of diazoacetates.

Authors:  Tatsuya Toma; Jun Shimokawa; Tohru Fukuyama
Journal:  Org Lett       Date:  2007-07-13       Impact factor: 6.005

7.  How nucleophilic are diazo compounds?

Authors:  Thorsten Bug; Manfred Hartnagel; Clemens Schlierf; Herbert Mayr
Journal:  Chemistry       Date:  2003-09-05       Impact factor: 5.236

8.  Preparation of Structurally Diverse Compounds from the Natural Product Lycorine.

Authors:  Sarah Z Tasker; Amanda E Cowfer; Paul J Hergenrother
Journal:  Org Lett       Date:  2018-09-11       Impact factor: 6.005

9.  Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

Authors:  E S Newlands; G R Blackledge; J A Slack; G J Rustin; D B Smith; N S Stuart; C P Quarterman; R Hoffman; M F Stevens; M H Brampton
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

10.  Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma.

Authors:  Riley L Svec; Lucia Furiassi; Christine G Skibinski; Timothy M Fan; Gregory J Riggins; Paul J Hergenrother
Journal:  ACS Chem Biol       Date:  2018-11-08       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.